Clinical Trial Update: Androgenic Alopecia TH07 Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial for androgenic alopecia is currently recruiting, evaluating a therapy labeled TH07 developed by Triple Hair Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenic Alopecia

Drugs mentioned

• TH07

Snippet

Sponsor: Triple Hair Inc | Conditions: Androgenic Alopecia | Phase 3 | Status: RECRUITING